Biopharmaceutical Contract Manufacturing Market Is Expected to Reach USD 25.1 Billion by ...

Retrieved on: 2024-08-06 14:21:11

Tags for this article:

Contract manufacturing organization

Drug manufacturing

Lonza Group

Samsung

Pharmaceutical industry

Sabyasachi Ghosh

Click the tags to see associated articles and topics

Biopharmaceutical Contract Manufacturing Market Is Expected to Reach USD 25.1 Billion by .... View article details on hiswai:

Summary

The article discusses the significant growth of the biopharma sector, driven by increasing demand for contract manufacturing organizations (CMOs) like Lonza Group and Samsung Biologics. Biopharma companies lack in-house capabilities and turn to CMOs, as highlighted by industry expert Sabyasachi Ghosh.

Article found on: www.digitaljournal.com

View Original Article